Total Positions
123
Quarter
2025 Q4
Top Holding
VERA (7.8%)
Top 10 Concentration
47.3%
Turnover Rate
23.4%
Sector HHI
0.18
Items per page:
1-25 of 123
| Stock | History | Sector / Type | Port % | Prev % | Rank / Prev | Conviction | Change | % Change | Influence | Shares | Mkt Value | Avg Cost | Price Held | 1st Owned | Source | Source Date | Date Reported |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
VERA
VERA THERAPEUTI...
|
Healthcare | 7.84% | 5.62% |
#1
4
Prev: #5
|
5.2 | 264,468 | 9.4% |
P
S
|
3,072,304 | $155,581,475 | 2022 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
QQQ
PUT
INVESCO QQQ TR
|
PUT Option | 6.97% | 9.52% |
#2
1
Prev: #1
|
2.8 | -5,000 | -2.2% |
P
S
|
225,000 | $138,219,750 | 2023 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
GSK
GSK PLC
|
Healthcare | 6.62% | 6.31% |
#3
Prev: #3
|
4.7 | 559,275 | 26.4% |
P
S
|
2,679,721 | $131,413,518 | 2018 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
UTHR
UNITED THERAPEU...
|
Healthcare | 6.20% | 7.32% |
#4
2
Prev: #2
|
2.5 | -628 | -0.2% |
P
S
|
252,592 | $123,075,452 | 2020 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
ABVX
ABIVAX SA
|
Healthcare | 4.47% | 2.50% |
#5
7
Prev: #12
|
4.0 | 231,335 | 54.2% |
P
S
|
657,834 | $88,712,204 | 2025 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
NTRA
NATERA INC
|
Healthcare | 3.86% | 5.76% |
#6
2
Prev: #4
|
1.7 | -185,151 | -35.6% |
P
S
|
334,493 | $76,629,001 | 2018 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
SNDX
SYNDAX PHARMACE...
|
Healthcare | 3.51% | 3.68% |
#7
1
Prev: #6
|
1.4 | -152,906 | -4.4% |
P
S
|
3,314,408 | $69,635,712 | 2022 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
VRDN
VIRIDIAN THERAP...
|
Healthcare | 2.79% | 2.86% |
#8
2
Prev: #10
|
1.1 | -142,071 | -7.4% |
P
S
|
1,782,235 | $55,463,153 | 2021 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
PCVX
VAXCYTE INC
|
Healthcare | 2.78% | 3.53% |
#9
2
Prev: #7
|
1.2 | -224,261 | -15.8% |
P
S
|
1,197,722 | $55,262,893 | 2022 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
TVTX
TRAVERE THERAPE...
|
Healthcare | 2.26% | 2.33% |
#10
5
Prev: #15
|
1.0 | -242,236 | -17.1% |
P
S
|
1,174,968 | $44,895,527 | 2024 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
HCA
HCA HEALTHCARE ...
|
Healthcare | 2.26% | 3.28% |
#11
2
Prev: #9
|
0.9 | -15,826 | -14.2% |
P
S
|
95,874 | $44,759,736 | 2020 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
DHR
DANAHER CORPORA...
|
Healthcare | 2.15% | 1.36% |
#12
10
Prev: #22
|
3.1 | 86,989 | 87.6% |
P
S
|
186,262 | $42,639,097 | 2018 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
IONS
IONIS PHARMACEU...
|
Healthcare | 2.15% | 2.43% |
#13
Prev: #13
|
0.9 | -443 | -0.1% |
P
S
|
538,218 | $42,578,426 | 2021 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
CLDX
CELLDEX THERAPE...
|
Healthcare | 1.96% | 2.06% |
#14
3
Prev: #17
|
2.9 | 280,805 | 24.3% |
P
S
|
1,434,725 | $38,967,131 | 2020 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
BRKR
BRUKER CORP
|
Healthcare | 1.86% | 1.54% |
#15
4
Prev: #19
|
2.8 | 96,660 | 14.1% |
P
S
|
783,789 | $36,924,300 | 2024 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
AVTR
AVANTOR INC
|
Healthcare | 1.83% | 0.80% |
#16
15
Prev: #31
|
3.0 | 2,252,202 | 243.6% |
P
S
|
3,176,644 | $36,404,340 | 2020 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
SPY
PUT
SPDR S&P 500 ET...
|
PUT Option | 1.54% | — |
#17
Prev: #—
|
2.6 | 44,900 | no change |
NEW
|
44,900 | $30,618,208 | 2021 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
CYH
COMMUNITY HEALT...
|
Healthcare | 1.25% | 1.54% |
#18
2
Prev: #20
|
2.5 | 993,751 | 14.3% |
P
S
|
7,943,802 | $24,784,662 | 2019 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
EXAS
EXACT SCIENCES ...
|
Healthcare | 1.24% | — |
#19
Prev: #—
|
2.5 | 241,678 | no change |
NEW
|
241,678 | $24,544,818 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
BCRX
BIOCRYST PHARMA...
|
Healthcare | 1.18% | 0.72% |
#20
14
Prev: #34
|
2.8 | 1,619,270 | 117.9% |
P
S
|
2,992,895 | $23,344,581 | 2017 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
GERN
GERON CORP
|
Healthcare | 1.17% | 1.19% |
#21
2
Prev: #23
|
2.6 | 5,060,981 | 40.2% |
P
S
|
17,659,983 | $23,311,178 | 2025 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
TECH
BIO-TECHNE CORP
|
Healthcare | 1.12% | 2.27% |
#22
6
Prev: #16
|
0.6 | -214,135 | -36.2% |
P
S
|
377,405 | $22,195,188 | 2022 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
CDTX
CIDARA THERAPEU...
|
Healthcare | 1.10% | — |
#23
Prev: #—
|
2.4 | 98,721 | no change |
NEW
|
98,721 | $21,806,482 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
PODD
INSULET CORP
|
Healthcare | 1.07% | 0.97% |
#24
1
Prev: #25
|
2.6 | 29,104 | 63.8% |
P
S
|
74,708 | $21,235,002 | 2018 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
BBNX
BETA BIONICS IN...
|
Healthcare | 1.04% | — |
#25
Prev: #—
|
2.4 | 678,262 | no change |
NEW
|
678,262 | $20,666,643 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
ZIMV
ZIMVIE INC
|
Unknown | 0.00% | 2.71% |
Sold All 😨
(Was: #11) |
0.3 | -2,079,380 | -100.0% |
CLOSED
|
— | $— | 2023 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
RGEN
REPLIGEN CORP
|
Healthcare | 0.00% | 0.97% |
Sold All 😨
(Was: #26) |
0.3 | -105,087 | -100.0% |
CLOSED
|
— | $— | 2021 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
RNA
AVIDITY BIOSCIE...
|
Healthcare | 0.00% | 0.91% |
Sold All 😨
(Was: #28) |
0.3 | -302,911 | -100.0% |
CLOSED
|
— | $— | 2025 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
NVO
NOVO-NORDISK A ...
|
Healthcare | 0.00% | 0.83% |
Sold All 😨
(Was: #29) |
0.3 | -217,708 | -100.0% |
CLOSED
|
— | $— | 2024 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
UTHR
PUT
UNITED THERAPEU...
|
PUT Option | 0.00% | 0.47% |
Sold All 😨
(Was: #46) |
0.3 | -16,200 | -100.0% |
CLOSED
|
— | $— | 2020 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
ETNB
89BIO INC
|
Unknown | 0.00% | 0.40% |
Sold All 😨
(Was: #48) |
0.3 | -392,441 | -100.0% |
CLOSED
|
— | $— | 2025 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
MRUS
MERUS N V
|
Healthcare | 0.00% | 0.31% |
Sold All 😨
(Was: #51) |
0.3 | -48,054 | -100.0% |
CLOSED
|
— | $— | 2020 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
MIRM
MIRUM PHARMACEU...
|
Healthcare | 0.00% | 0.25% |
Sold All 😨
(Was: #56) |
0.3 | -49,314 | -100.0% |
CLOSED
|
— | $— | 2025 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
NKTR
NEKTAR THERAPEU...
|
Healthcare | 0.00% | 0.20% |
Sold All 😨
(Was: #60) |
0.3 | -49,890 | -100.0% |
CLOSED
|
— | $— | 2025 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
GOSS
GOSSAMER BIO IN...
|
Healthcare | 0.00% | 0.17% |
Sold All 😨
(Was: #63) |
0.3 | -925,233 | -100.0% |
CLOSED
|
— | $— | 2021 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
KURA
KURA ONCOLOGY I...
|
Healthcare | 0.00% | 0.16% |
Sold All 😨
(Was: #64) |
0.3 | -263,628 | -100.0% |
CLOSED
|
— | $— | 2023 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
KRRO
KORRO BIO INC
|
Healthcare | 0.00% | 0.07% |
Sold All 😨
(Was: #76) |
0.3 | -20,856 | -100.0% |
CLOSED
|
— | $— | 2025 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
PVLA
PALVELLA THERAP...
|
Healthcare | 0.00% | 0.05% |
Sold All 😨
(Was: #80) |
0.3 | -11,343 | -100.0% |
CLOSED
|
— | $— | 2025 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
ATYR
PUT
ATYR PHARMA INC
|
PUT Option | 0.00% | 0.03% |
Sold All 😨
(Was: #82) |
0.3 | -658,000 | -100.0% |
CLOSED
|
— | $— | 2025 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
REPL
REPLIMUNE GROUP...
|
Healthcare | 0.00% | 0.02% |
Sold All 😨
(Was: #84) |
0.3 | -59,992 | -100.0% |
CLOSED
|
— | $— | 2025 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
DYN
DYNE THERAPEUTI...
|
Healthcare | 0.00% | 0.01% |
Sold All 😨
(Was: #86) |
0.3 | -10,000 | -100.0% |
CLOSED
|
— | $— | 2025 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) |
Showing 1-25 of 123 holdings